Inventor · disambiguated record
Nicolas Sebastien Wein
Also filed as: WEIN NICOLAS · WEIN NICOLAS SEBASTIEN
6 granted patents·8 pending applications·15 citations·filing 2014–2022
77Inventor score
Files withRES INST NATIONWIDE CHILDRENS HOSPITAL12RES INSTITUTE AT NATIONWIDE CHILDREN’S HOSPITAL1THE RES INSTITUTE AT NATIONWIDE CHILDRENS HOSPITAL1
Top patents by PatentIndex Score
14 records- 0188US11180755B2Recombinant virus products and methods for inducing DUX4 exon skippingRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2017·Granted Nov 23, 2021·4 cites·7 claims
- 0284US11230707B2Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructsRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2018·Granted Jan 25, 2022·3 cites·17 claims
- 0380US11053494B2Methods and materials for activating an internal ribosome entry site in exon 5 of the DMD geneTHE RES INSTITUTE AT NATIONWIDE CHILDRENS HOSPITAL·Filed 2015·Granted Jul 6, 2021·2 cites·27 claims
- 0477US9862945B2Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructsRES INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL·Filed 2014·Granted Jan 9, 2018·6 cites·14 claims
- 0572US12084658B2Recombinant virus products and methods for inducing DUX4 exon skippingRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2021·Granted Sep 10, 2024·0 cites·6 claims
- 0667US12492402B2Recombinant virus products and methods for inhibiting expression of dystrophia myotonica protein kinase and/or interfering with a trinucleotide repeat expansion in the 3′ untranslated region of the DMPK geneRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2019·Granted Dec 9, 2025·0 cites·12 claims
- 0767US2023025574A1Recombinant Adeno-Associated Virus Delivery of Exon 2-Targeted U7SNRNA Polynucleotide ConstructsRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2021·Application pending·0 cites
- 0860US2022127607A1Methods and materials for activating an internal ribosome entry site in exon 5 of the dmd geneRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2021·Application pending·0 cites
- 0957US2024209360A1Products and methods for inducing exon 2 skipping of the dmd gene in treating muscular dystrophyRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2022·Application pending·0 cites
- 1055US2024398861A1Enhanced cell-derived vesicles for cancer therapyRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2022·Application pending·0 cites
- 1155US2024261434A1Products and methods for treating muscular dystrophyRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2021·Application pending·0 cites
- 1254US2024200066A1Products and methods for treating muscular dystrophyRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2022·Application pending·0 cites
- 1353US2024026356A1Compositions and methods for treating facioscapulohumeral muscular dystrophy (fshd)RES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2021·Application pending·0 cites
- 1451US2022282247A1Exon 44-targeted nucleic acids and recombinant adeno-associated virus comprising said nucleic acids for treatment of dystrophin-based myopathiesRES INST NATIONWIDE CHILDRENS HOSPITAL·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicolas Sebastien Wein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →